Comments of DPR's RCD for Imidacloprid

OEHHA has provided a number of comments on the risk characterization methodology and conclusions on the draft RCD for Imidacloprid. These comments and our recommendations, as well as suggested clarifications, additions and corrections, are contained in this report.

Downloads

Comments of DPR's RCD for ImidaclopridSep 30, 2005

Chemical Reference

• Imidacloprid